Hypertrophic cardiomyopathy with mid-ventricular obstruction and splenic infarction associated with paroxysmal atrial fibrillation: a case report.
A 54-year-old woman had been treated for hypertrophic cardiomyopathy and paroxysmal atrial fibrillation since 1992. She was admitted with paroxysmal atrial fibrillation which was resolved by medical treatment. However, on the next day, left lateral chest pain appeared. Computed tomography disclosed a low density area in the spleen. She received anticoagulant therapy under a diagnosis of splenic infarction, and the pain disappeared. Echocardiography showed hypertrophic cardiomyopathy with mid-ventricular obstruction. She was treated with cibenzoline to prevent paroxysmal atrial fibrillation attack and attenuate the hemodynamic load. After treatment, the pressure gradient decreased from 41 to 7 mmHg. This patient with hypertrophic cardiomyopathy suffered a rare isolated splenic infarction associated with paroxysmal atrial fibrillation.
Tokuyasu
K
K
Second Department of Internal Medicine, Ehime University School of Medicine.
Hara
Y
Y
Matsumoto
Y
Y
Hashida
H
H
Ikeda
S
S
Ohtsuka
T
T
Hiasa
G
G
Kitami
Y
Y
Shigematsu
Y
Y
Hamada
M
M
Hiwada
K
K
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications*; D004452:Echocardiography; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008875:Middle Aged; D013159:Splenic Infarction / Q000000981:diagnostic imaging / Q000209:etiology*; D014057:Tomography, X-Ray Computed; D014694:Ventricular Outflow Obstruction / Q000209:etiology
D000889:Anti-Arrhythmia Agents; D007093:Imidazoles; C032151:cifenline